ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Conditions: Leiomyosarcoma; Liposarcoma Intervention: Drug: ATX-101 Sponsor: Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Conditions: Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Leiomyosarcoma; Liposarcoma; Angiosarcoma; Synovial Sarcoma; Rhabdomyosarcoma; Spindle Cell Sarcoma; High Grade Sarcoma; Bone Sarcoma; Osteosarcoma; Ewing Sarcoma of Bone Interventions: Drug: Gemcitabine; Drug: 9-ING-41; Drug: Docetaxel Sponsors: Brown University; Actuate Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Conditions: Leiomyosarcoma; Liposarcoma Intervention: Drug: ATX-101 Sponsor: Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Conditions: Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Leiomyosarcoma; Liposarcoma; Angiosarcoma; Synovial Sarcoma; Rhabdomyosarcoma; Spindle Cell Sarcoma; High Grade Sarcoma; Bone Sarcoma; Osteosarcoma; Ewing Sarcoma of Bone Interventions: Drug: Gemcitabine; Drug: 9-ING-41; Drug: Docetaxel Sponsors: Brown University; Actuate Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Conditions: Leiomyosarcoma; Liposarcoma Intervention: Drug: ATX-101 Sponsor: Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Conditions: Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Leiomyosarcoma; Liposarcoma; Angiosarcoma; Synovial Sarcoma; Rhabdomyosarcoma; Spindle Cell Sarcoma; High Grade Sarcoma; Bone Sarcoma; Osteosarcoma; Ewing Sarcoma of Bone Interventions: Drug: Gemcitabine; Drug: 9-ING-41; Drug: Docetaxel Sponsors: Brown University; Actuate Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Conditions: Leiomyosarcoma; Liposarcoma Intervention: Drug: ATX-101 Sponsor: Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Conditions: Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Leiomyosarcoma; Liposarcoma; Angiosarcoma; Synovial Sarcoma; Rhabdomyosarcoma; Spindle Cell Sarcoma; High Grade Sarcoma; Bone Sarcoma; Osteosarcoma; Ewing Sarcoma of Bone Interventions: Drug: Gemcitabine; Drug: 9-ING-41; Drug: Docetaxel Sponsors: Brown University; Actuate Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Conditions: Leiomyosarcoma; Liposarcoma Intervention: Drug: ATX-101 Sponsor: Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Conditions: Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Leiomyosarcoma; Liposarcoma; Angiosarcoma; Synovial Sarcoma; Rhabdomyosarcoma; Spindle Cell Sarcoma; High Grade Sarcoma; Bone Sarcoma; Osteosarcoma; Ewing Sarcoma of Bone Interventions: Drug: Gemcitabine; Drug: 9-ING-41; Drug: Docetaxel Sponsors: Brown University; Actuate Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Conditions: Leiomyosarcoma; Liposarcoma Intervention: Drug: ATX-101 Sponsor: Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials
